Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 11 - Drugs for disorders of the respiratory system
Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767)
05/2012
05/23/2012CN102018843B Chinese medicinal composition for treating cough
05/23/2012CN102000105B Compound timicosin oral liquid and preparation method thereof
05/23/2012CN101991728B Preparation method of Ditong rhinitis water
05/23/2012CN101966285B Traditional Chinese medicine and traditional Chinese medicine aerosol for preventing and curing chicken respiratory diseases and preparation method thereof
05/23/2012CN101962398B Separating identification of new compound furostanol saponin in smilacina japonica and antitumor application thereof
05/23/2012CN101948539B IL-18 binding proteins
05/23/2012CN101934027B Oral Chinese traditional medicine for treating chronic pharyngolaryngitis
05/23/2012CN101926908B Chinese medicinal composition for treating cold
05/23/2012CN101914428B Grosvener siraitia vinegar for removing heat from the lung to relieve cough and preparation method thereof
05/23/2012CN101904885B Medicinal composition for treating allergic rhinitis and preparation method and application thereof
05/23/2012CN101899058B Method for preparing thiazolopyrimidine compound, thiazolopyrimidine compound and application thereof
05/23/2012CN101884655B Method for preparing pseudo-ginseng flower extract
05/23/2012CN101879271B Quality detection method of red tangerine peel capsule
05/23/2012CN101879197B Turpinia Montana leaf ethanol reflux extractive, preparation method and application thereof
05/23/2012CN101850014B Chinese medicament for treating asthma
05/23/2012CN101843586B Water-soluble micro powder containing florfenicol and preparation method thereof
05/23/2012CN101829255B Method for preparing traditional Chinese medicine Pinellia ternata
05/23/2012CN101787358B Tet-Off Advanced human stably expressing high-transition nasopharyngeal carcinoma cell line S18, construction method thereof and application thereof
05/23/2012CN101785838B Lung cancer treatment medicine
05/23/2012CN101773563B Medicine composition
05/23/2012CN101766800B Quality detection method of pills for treating cold and expelling wind
05/23/2012CN101766662B Process for efficiently concentrating cordycepin
05/23/2012CN101756942B Oral lung inhalation aerosol powder
05/23/2012CN101732608B Method for detecting quality of mulberry and chrysanthemum lonicera and forsythia powder
05/23/2012CN101732554B Medicament for treating pediatric respiratory tract infection and pulmonary infection
05/23/2012CN101732552B Method for detecting quality of lung clearing and phlegm eliminating pill
05/23/2012CN101721437B Preparation method of medicine composition used for treating chronic pharyngitis
05/23/2012CN101700349B Liquid hard capsule of Anagex extract and preparation method thereof
05/23/2012CN101687883B Modulators of cystic fibrosis transmembrane conductance regulator
05/23/2012CN101648009B Method for preparing cordycepin SOD medicinal granules
05/23/2012CN101616925B Tricyclic compounds and their use as glucocorticoid receptor modulators
05/23/2012CN101579384B Rhinitis healing ointment and preparation method and using method thereof
05/23/2012CN101544631B Novel pyrazole 5-lipoxygenase small molecule inhibitors, preparation method, pharmaceutical composition and application thereof
05/23/2012CN101530437B Method for extracting flavonoid compound from bracken
05/23/2012CN101474238B Persimmon leaf soft capsule preparation and preparation method thereof
05/23/2012CN101282716B Pharmaceutical composition of pranlukast solid-dispersion with improved initial dissolution rate and the method of preparing the same
05/23/2012CN101219193B Medicament for clearing heat, eliminating phlegm and relieving cough
05/23/2012CN101203507B 2-substituted benzimidazoles
05/23/2012CN101199845B Stable anti-IgE humanized single anti-agent
05/23/2012CN101199635B Medicament for treating rhinitis
05/23/2012CN101142208B 1,3-dihydro-benzimidazol-2-ylidene amines as inhibitors of respiratory syncytial virus replication
05/23/2012CN101138566B Prevention and treatment process for infectious diseases and other diseases by using immunity effect compounds
05/23/2012CN101119978B HSP90-inhibiting triazole derivatives
05/23/2012CN101103013B 1-thio-D-glucitol derivatives
05/23/2012CN101053600B Medicinal composition for treating cough and preparation method and application thereof
05/22/2012US8183361 Oligonucleotide-containing pharmacological compositions and their use
05/22/2012US8182837 Methods and compositions for reducing the risk associated with the administration of opioid analgesics in patients with diagnosed or undiagnosed respiratory illness
05/22/2012US8182791 Free-flowing fine particle mixtures comprising carrier particles, active drug particles and stabilizer particles, for respiratory system disorders; medical equipment
05/22/2012CA2561828C Use of a trioxopyrimidine for the treatment and prevention of bronchial inflammatory diseases
05/22/2012CA2533791C Medicaments for inhalation comprising betamimetics and an anticholinergic agent
05/22/2012CA2442326C Imidazolyl derivatives useful as histamine h3 receptor ligands
05/22/2012CA2436107C Kyberdrug as autovaccines with immune-regulating effects
05/18/2012WO2012064340A1 Dual-action compounds targeting adenosine a2a receptor and adenosine transporter for prevention and treatment of neurodegenerative diseases
05/18/2012WO2012062780A1 Non-replicating probiotic micro-organisms protect against upper respiratory tract infections
05/18/2012WO2012062031A1 Drink of nourishing lung
05/18/2012WO2012061972A1 Selective glycosidase inhibitors and uses thereof
05/18/2012WO2012061971A1 Selective glycosidase inhibitors and uses thereof
05/18/2012WO2012061902A1 Micronised spray-dried particles comprising polymyxin
05/18/2012WO2012024620A3 Autotaxin inhibitors and uses thereof
05/18/2012WO2012021291A3 Methods of treating obstructive lung diseases using bitter tastants
05/18/2012WO2012014085A3 Uses of cimiracemate a and related compounds for treating inflammation and modulating immune responses
05/18/2012CA2817689A1 Non-replicating probiotic micro-organisms protect against upper respiratory tract infections
05/17/2012US20120122977 Substituted amino bisphenyl pentanoic acid derivatives as NEP inhibitors
05/17/2012US20120122960 Organic Compositions to Treat Beta-ENaC-Related Diseases
05/17/2012US20120122948 3-alkyl-5-fluoroindole derivatives as myeloperoxidase inhibitors
05/17/2012US20120122942 5-oxo-ete receptor antagonist compounds
05/17/2012US20120122930 1H-Benzimidazole-5-Carboxamides As Anti-Inflammatory Agents
05/17/2012US20120122926 Biphenyl compounds useful as muscarinic receptor antagonists
05/17/2012US20120122924 Nampt inhibitors
05/17/2012US20120122922 Compositions of n-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide
05/17/2012US20120122921 Process for making modulators of cystic fibrosis transmembrane conductance regulator
05/17/2012US20120122917 Method For Treatment Of HIV And Diseases Of Immune Dysregulation
05/17/2012US20120122909 Spiro-oxindole compounds and their uses as therapeutic agents
05/17/2012US20120122894 Inhibitors of bruton's tyrosine kinase
05/17/2012US20120122889 Small molecule inhibitors of necroptosis
05/17/2012US20120122861 Bicyclic amide derivatives for enhancing glutamatergic synaptic responses
05/17/2012US20120122859 Methods of using diaminopyrimidine as p2x3 and p2x2/3 receptor modulators for treatment of respiratory and gastrointestinal diseases
05/17/2012US20120122857 Heterobicyclic carboxamides as inhibitors for kinases
05/17/2012US20120122852 Tricyclic n-heteroaryl-carboxamide derivatives containing a benzimidazole unit, method for preparing same and their therapeutic use
05/17/2012US20120122850 Biphenyl compounds useful as muscarinic receptor antagonists
05/17/2012US20120122842 Nampt and rock inhibitors
05/17/2012US20120122827 Novel derivatives of cholest-4-en-3-one oxime, pharmaceutical compositions containing them and preparation method
05/17/2012US20120122826 Novel quinuclidine derivatives and medicinal compositions containing the same
05/17/2012US20120122824 Reduction of Side Effects From Aromatase Inhibitors Used for Treating Breast Cancer
05/17/2012US20120122818 Lung-targeted drugs
05/17/2012US20120122817 Heterocyclic urea derivatives and methods of use thereof
05/17/2012US20120122810 Fused Pentacyclic Polyethers
05/17/2012US20120122768 Alginate oligomers for use in overcoming multidrug resistance in bacteria
05/17/2012US20120122764 Substituted carbamoylcycloalkyl acetic acid derivatives as nep
05/17/2012US20120122763 Novel tetrahydrocarbazole derivatives as ligands of g-protein coupled receptors
05/17/2012US20120122762 186 Human Secreted Proteins
05/17/2012US20120121730 Pharmaceutical and nutraceutical compositions for treating respiratory disease and associated phlegm
05/17/2012US20120121729 Antitussive compositions comprising memantine
05/17/2012US20120121724 Film comprising therapeutic agents
05/17/2012US20120121720 Modulation of Beta 2 Adrenergic Receptors by Inhibitors of EGLN3 or pVHL
05/17/2012US20120121715 DNA Vaccine Comprising IL-6-Encoding DNA Construct and Applications Thereof
05/17/2012US20120121697 Compositions and Methods for the Diagnosis and Treatment of Inflammatory Disorders and Fibrotic Disease
05/17/2012US20120121668 Compositions for oral adminstration of active principles requiring masking of taste
05/17/2012US20120121654 Nanoparticle isoflavone compositions & methods of making and using the same
05/17/2012US20120121653 Novel mometasone compositions and methods of making and using the same
1 ... 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 ... 878